enGene Holdings Inc. Warrants (ENGNW)

• Market cap: $7.08M
• 1 day: 4.62%
• 5 days: -2.86%
• 1 month: -25.27%
• 3 months: -15%
• 6 months: -5.56%
• Year to date: -24.44%
• 1 year: -38.18%
• 5 years: -32%
• 10 years: -32%
• Sector: Healthcare
• Industry: Biotechnology

About: enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Employees: 57

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

36.39% more ownership

Funds ownership: 9.34% [Q1] → 45.73% (+36.39%) [Q2]

27% more capital invested

Capital invested by funds: $2.91M [Q1] → $3.7M (+$791K) [Q2]

7% more funds holding

Funds holding: 14 [Q1] → 15 (+1) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1